Intent to Sole Source - Endotoxin Detection System Cartridges

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Notice type
Special Notice
Solicitation #
NOI-CC-OLAO-26-007979
NAICS
325414
PSC
6640
Set-aside
No Set aside used
Posted
August 4, 2026
Response due
August 7, 2026
Place of performance
Bethesda, MD

What this opportunity is

The Department of Health and Human Services intends to negotiate a sole-source contract with Charles River Laboratories for endotoxin detection system cartridges used in bacterial endotoxin testing for PET IND products. This opportunity is not set aside for small businesses, and it is a Special Notice rather than a Request for Proposal, meaning interested parties should submit capability statements rather than bids. The cartridges are proprietary to the PTS units, and timely delivery is critical to ensure compliance with testing requirements for patient use.

Analysis by Mindy, grounded in the SAM.gov notice.

Description

This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Charles River Laboratories. Acquisition Description: The PET Radiopharmacy uses Charles River Laboratories’ FDA licensed endotoxin detection system, a portable testing system (PTS) to ensure all manufactured PET IND products are pyrogen-free prior to release. The PTS utilizes disposable cartridges unique to the system. At least one cartridge is needed for every PET IND produced. The endotoxin detection system cartridges are estimated to cost $22,200 and is required to be delivered by 08/24/2026. The PTS and cartridges are used for bacterial endotoxin testing required for each PET IND produced. Because of the proprietary of these cartridges to our PTS units, only one source is solicited. The cartridges must be delivered by 02/01/2025. If the required delivery date is not met, there will not be enough cartridges available to perform testing required to release of PET IND products for patient use. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-007979) by 12:00 PM eastern standard time on 08/07/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

Source: SAM.gov, as posted. Verify the current solicitation before responding.

Pursue this opportunity with Mindy

See who holds it now, who else is bidding, and draft your response — grounded in real government data, not generic AI.

View the original notice on SAM.gov ↗

Similar Active Opportunities (NAICS 325414)